Suppr超能文献

κ阿片受体激动剂介导的抗伤害感受被δ受体激动剂阻断。

Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.

作者信息

Taylor A M W, Roberts K W, Pradhan A A, Akbari H A, Walwyn W, Lutfy K, Carroll F I, Cahill C M, Evans C J

机构信息

University of California, Los Angeles, CA, USA; University of California Irvine, Irvine, CA, USA.

出版信息

Br J Pharmacol. 2015 Jan;172(2):691-703. doi: 10.1111/bph.12810. Epub 2014 Sep 5.

Abstract

BACKGROUND AND PURPOSE

The opioid receptor family comprises four structurally homologous but functionally distinct sub-groups, the μ (MOP), δ (DOP), κ (KOP) and nociceptin (NOP) receptors. As most opioid agonists are selective but not specific, a broad spectrum of behaviours due to activation of different opioid receptors is expected. In this study, we examine whether other opioid receptor systems influenced KOP-mediated antinociception.

EXPERIMENTAL APPROACH

We used a tail withdrawal assay in C57Bl/6 mice to assay the antinociceptive effect of systemically administered opioid agonists with varying selectivity at KOP receptors. Pharmacological and genetic approaches were used to analyse the interactions of the other opioid receptors in modulating KOP-mediated antinociception.

KEY RESULTS

Etorphine, a potent agonist at all four opioid receptors, was not anti-nociceptive in MOP knockout (KO) mice, although etorphine is an efficacious KOP receptor agonist and specific KOP receptor agonists remain analgesic in MOP KO mice. As KOP receptor agonists are aversive, we considered KOP-mediated antinociception might be a form of stress-induced analgesia that is blocked by the anxiolytic effects of DOP receptor agonists. In support of this hypothesis, pretreatment with the DOP antagonist, naltrindole (10 mg·kg(-1) ), unmasked etorphine (3 mg·kg(-1) ) antinociception in MOP KO mice. Further, in wild-type mice, KOP-mediated antinociception by systemic U50,488H (10 mg·kg(-1) ) was blocked by pretreatment with the DOP agonist SNC80 (5 mg·kg(-1) ) and diazepam (1 mg·kg(-1) ).

CONCLUSIONS AND IMPLICATIONS

Systemic DOP receptor agonists blocked systemic KOP antinociception, and these results identify DOP receptor agonists as potential agents for reversing stress-driven addictive and depressive behaviours mediated through KOP receptor activation.

LINKED ARTICLES

This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.

摘要

背景与目的

阿片受体家族由四个结构同源但功能不同的亚组组成,即μ(MOP)、δ(DOP)、κ(KOP)和孤啡肽(NOP)受体。由于大多数阿片类激动剂具有选择性但不具有特异性,因此预计不同阿片受体激活会引发广泛的行为。在本研究中,我们研究了其他阿片受体系统是否会影响KOP介导的镇痛作用。

实验方法

我们在C57Bl/6小鼠中使用甩尾试验来测定全身给予的对KOP受体具有不同选择性的阿片类激动剂的镇痛效果。采用药理学和遗传学方法分析其他阿片受体在调节KOP介导的镇痛作用中的相互作用。

关键结果

埃托啡是所有四种阿片受体的强效激动剂,在MOP基因敲除(KO)小鼠中无镇痛作用,尽管埃托啡是一种有效的KOP受体激动剂,且特异性KOP受体激动剂在MOP KO小鼠中仍具有镇痛作用。由于KOP受体激动剂具有厌恶作用,我们认为KOP介导的镇痛作用可能是应激诱导镇痛的一种形式,可被DOP受体激动剂的抗焦虑作用所阻断。支持这一假设的是,用DOP拮抗剂纳曲吲哚(10mg·kg⁻¹)预处理可使埃托啡(3mg·kg⁻¹)在MOP KO小鼠中发挥镇痛作用。此外,在野生型小鼠中,全身给予U50,488H(10mg·kg⁻¹)介导的KOP镇痛作用可被DOP激动剂SNC80(5mg·kg⁻¹)和地西泮(1mg·kg⁻¹)预处理所阻断。

结论与意义

全身给予DOP受体激动剂可阻断全身KOP镇痛作用,这些结果表明DOP受体激动剂是逆转通过KOP受体激活介导的应激驱动的成瘾和抑郁行为的潜在药物。

相关文章

本文是关于阿片类药物:功能选择性新途径主题部分的一部分。要查看本部分的其他文章,请访问http://dx.doi.org/10.1111/bph.2015.172.issue-2。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb9b/4292979/ce5e66500038/bph0172-0691-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验